Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic Vaccine

Update Il y a 4 ans
Reference: NCT00562237

Woman and Man

Extract

Several combinations of H5N1 antigen concentrations and aluminium-hydroxide adjuvant concentrations will be tested for their safety and capacity to induce a specific immune response.


Inclusion criteria

  • Healthy subjects

Links